Software firm aims to enter primary care space

Digital care software company Servelec has said it intends to enter the primary care space for the first time.

The company will add some of its solutions and those of selected partners to the recently announced GP IT Futures framework.

Neil Laycock, managing director at Servelec, said: “The GP IT Futures full tender is now out and is set to deliver the next iteration of the GP IT Systems, procured centrally and chosen locally. Most importantly, it provides the opportunity to increase the pace of digital innovation across primary care, and support the creation and running of primary care networks across England.

“This framework will help to deliver the vision set out by the NHS, through the Secretary of State, and NHSX and Digital, to provide innovative solutions that interoperate and support a more integrated way of working – not just in GP practices, but across primary care and community health. It gives Servelec a clear opportunity to leverage the knowledge we have in developing and delivering interoperable software in secondary care – extending it into primary care to help deliver seamless solutions for better outcomes.

“We will be adding some of our solutions to the framework, marking our first step into the primary care space. Whilst we are not at present aiming to deliver a primary care core system, we are aiming through our own solutions, and those of selected partners, to spearhead some of the innovation and change the NHS wants and needs.”

Servelec aims to enable integration with social prescribing providers, mobile community-based working, whilst providing solutions for primary care to integrate more closely with community services and social care sectors, as part of the move into primary care networks. By joining the framework, Servelec will be instrumental in bringing some real choice in how the capabilities stated in the framework are delivered.


'Software firm aims to enter primary care space' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions